Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nobody likes being down is all I was getting at. Chill. I’m heavily invested here. AND NOT WORRIED AT ALL. VERY EXCITING ON THE WAY.
Well, my .0034 avg. (5.6mil) is sucking right now. Too low to sell so I’ll ride it out. Scared money is perpetuating the selling.
I’ve got a big order at par.001 if it gets that low. Frankly I hope it does. The average down would be awesome!
There’s nothing wrong with this company or LACTOACTIVE. FOLKS EITHER SEE THE VALUE OR NOT.
There is a lot of good information that has been PR by the company. All one has to do read and have a little forward thinking as to the potential money that is to be made with the LACTOACTIVE patent.
More exciting news:
Vilacto Bio Unveils Development Programs for LACTOACTIVE iTHER®
Press Release | 09/21/2018
COPENHAGEN, Denmark, Sept. 21, 2018 (GLOBE NEWSWIRE) — Vilacto Bio Inc. (OTC QB:VIBI) has revealed the initial five areas of development for its new LACTOACTIVE iTHER® compound.
LACTOACTIVE iTHER® is a new LACTOACTIVE variant that combines potent immune-system enhancement with a proven nanoparticle drug delivery system.
“Our own research suggests, and we firmly believe, that LACTOACTIVE iTHER® can contribute significantly to emerging therapies for treating a number of diseases, including cancer, immunodeficiency disorders, osteoarthritis, psoriasis, thrombocytopenia and others,” said
Vilacto Bio CEO Gert Anderson.
The areas where LACTOACTIVE iTHER® will be developed first include:
A bio-injection that could be useful in preventing metastasis of malignant tumor cells in cancer treatment due to the hydrocolloid potent (HA).
An inhaler spray to prevent recurrent upper respiratory tract infections (based on a 2016 study)
A vaccine injection for nanoparticle antibody source for a vaccine producer.
A new variant of gelatin capsules for patients with arthritis and other joint inflammation with fewer side effects – especially hypertension if people with diabetes – than Glucosamine.
Gums and candies and mouthwash, toothpaste for people with immune system deficiency, undergoing chemotherapy and suffering from oral inflammation.
These development programs are part of Vilacto Bio’s LACTOACTIVE iTHER® plan to form strategic partnerships with other biotech firms and become the “go-to” partner for enhancing new immunotherapy and vaccine solutions with its refined-colostrum compound “weaponized” as a nanomedicine.
They did post a PR. Check out their website: https://vilactobio.com/vilacto-bio-canada-patent-lactoactive-granted/
As for direction of the company:
“The patent applications in Canada also cover the Company’s new compound, LACTOACTIVE iTHER®, a LACTOACTIVE® variant that offers potent immune-system enhancement with a potential for treating a wide range of diseases. LACTOACTIVE iTHER® is expected to generate new revenue streams in addition to the company’s LACTOACTIVE®-based therapeutic skincare range.
“Vilacto Bio now is in a stronger position than ever to leverage the potential of LACTOACTIVE,” said Vilacto Bio CEO Gert Anderson.”
Hi everyone. DD is solid here (thanks Majk76). When it breaks those without a position will be wishing they had one.
FIRST PATENT HAS BEEN ISSUED
MULTIPLE INTERNATIONAL PATENT APPLIED FOR.
THE TECHNOLOGY IS REVOLUTIONARY
THE APPLICATIONS SPAN NUMEROUS MARKETS!
NANOTECHNOLOGY FOR SKIN ABSORPTION!!!!
YEA, LACTOACTIVE WILL BE THE GOLD STANDARD IN EVERY PHARMACEUTICAL PRODUCT. IMO
IF ITS APPLIED TO THE SKIN; LACTOACTIVE GETS IT IN!!!!(has a nice ring to it)
VIBI IS A NO BRAINER. $$$$$$$$$$$$$$
Every time it prints a 5 digit trade of 10,000 we go backwards. I guess I’m paranoid but I believe MMs are providing resistance with their own shares.
ALL THIS TELLS ME IS WE GO MUCH HIGHER SOON. THEY CANT HOLD IT BACK ANY LONGER!
MULTIPLE STREAMS OF REVENUE, Big announcements on the horizon. They didn’t upgrade the plant because they were board.
TIME TO CAPITALIZE ON THE LACTOACTIVE PATENT!IMO
“licensing out our Lactoactive®molecule for the pharmaceutical industry.”
Vilacto Bio Inc. Upgrades Denmark Plant; Paves Way for New LACTOACTIVE iTHER® to Stimulate Local Antibody ProductionPress Release | 05/23/2018
We aim to further develop our Lactoactive®molecule for the purpose of increasing the quality of our retail and medical skin cream products as well as licensing out our Lactoactive®molecule for the pharmaceutical industry.
Standoff. But the bulls will win the day. Way to much upside to not have position in VIBI. SEE Majk76 STICKY! EXCELLENT DD. IMO
FALSE STATEMENT. Come back to planet earth; please
Excellent DD. STICKY PLEASE!
Thank you.
It will be interesting to know how many panic sellers yesterday will be able to re- purchase those shares at or below their previous average.
By the comments I’m reading lots of folks intend to buy back today.
Will the market allow a low re entry? I don’t think so. So I held my shares for ride. I don’t think it’s possible for people to resist the catalysts here and the potential of VIBI.
So, I will see if my play was correct or suffer through the bottom and just average down.
I really think buying pressure is going to drive it past .0067.
VIBI felt they had to protect the company from a hostile takeover. So something had to have happened that made them feel threatened.
Makes me all the more confident that we are headed for a life changing share price. I can’t wait for the next PR. all IMO
WOW! 189,568,710 volume by 2:20 eastern. $$$$$$$$$$$
I love LACTOACTIVE iTHER!
LACTOACTIVE iTHER®
LACTOACTIVE iTHER® is a type of nanotherapy with particles that range from 10 nm to 300 nm in diameter. The particles consist of refined colostrum and other ingredients that both contain vital antibodies and stimulate the immune system to fight diseases, including:
?
Cancer
?
Immunodeficiency disorders
?
Osteoarthritis
?
Psoriasis
?
Thrombocytopenia
?
Vitiligo
Other demonstrable benefits include anti-inflammation and growth-stimulation properties.
Brilliant. I laughed so much I missed a trade, but it was worth it!
OMG! I’m laughing sooooo hard at that spelling!!!!!
NICELY DONE
Don’t respond to my posts and I will not respond to yours.
You bring nothing of value here. Please move on.
Rounded the corner and level 2 is thin. Should be fun the rest the day. IMO
proven nanoparticle drug delivery system (NDDS).
Not going to miss out! $$$$$$
PATENT SMELL LIKE MONEY: “proven nanoparticle drug delivery system (NDDS).”
Immunotherapy and vaccine treatments for a wide range of diseases
Havin successfully launched its Vilact range of skincare therapies based on LACTOACTIVE®, Vilacto Bio is devoting its full resources to the pre-clinical development of immunotherapy and vaccine treatments for a wide range of diseases. These treatment approaches are based on LACTOACTIVE iTHER®, a new LACTOACTIVE® variant that combines potent immune-system enhancement with a proven nanoparticle drug delivery system (NDDS).
The patent applications in Canada also cover the Company’s new compound, LACTOACTIVE iTHER®, a LACTOACTIVE® variant that offers potent immune-system enhancement with a potential for treating a wide range of diseases. LACTOACTIVE iTHER® is expected to generate new revenue streams in addition to the company’s LACTOACTIVE®-based therapeutic skincare range.
I love the patent. Poised to be the gold standard for ALL skin applied products, drugs, patches, etc. $$$$$$$$$$IMO
Vilacto Bio Canada Patent LACTOACTIVE® Granted
Press Release | 03/15/2019
NEW YORK, March 15, 2019 (GLOBE NEWSWIRE) -- Denmark-based Vilacto Bio Inc. (OTC QB:VIBI) is happy to announce that the Canadian Intellectual Property Office (CIPO) has informed the Company that its patent application for LACTOACTIVE® will be issued in near future.
The Company has already filed and received patents covering LACTOACTIVE® in the US, Europe and Hong Kong. The Canadian patent, when issued, is expected to give the company greater scope to continue developing the LACTOACTIVE® compound and bolster its international IP ownership position.
The patent applications in Canada also cover the Company’s new compound, LACTOACTIVE iTHER®, a LACTOACTIVE® variant that offers potent immune-system enhancement with a potential for treating a wide range of diseases. LACTOACTIVE iTHER® is expected to generate new revenue streams in addition to the company’s LACTOACTIVE®-based therapeutic skincare range.
“Vilacto Bio now is in a stronger position than ever to leverage the potential of LACTOACTIVE,” said Vilacto Bio CEO Gert Anderson.
153,602,220 shares traded by 12:38 Eastern. VERY IMPRESSIVE DAY AFTER DAY. BIGGER THINGS TO COME IMO.
Very well stated. Thank you.
Same, I bought more on dip at .044. All free. I love the Ichimoku Cloud.
NICE FINISH
Hilarious! MMs trying not to let it run, but L2 is about tapped out. Where’s my popcorn???
Accumulation turned up like fish hook. RSI is headed for the sky and MACD gaining altitude. This is truly going to be fun! I can’t wait for PRs.
THAT IS WHY IM ALL IN. THIS IS MUCH BIGGER THAN EXPECTED.
Thanks for the update.
Thanks Pepsi. Glad to be here!
Thanks. I’m pulling for all of us. We need a good win and VIBI is set up and ready to fly.
Hi folks. I got in at .19 and more at .003 today. 5.6mil shares.
The potential usages for LACTOACTIVE goes far beyond just beauty products. The patented skin absorption process transcends all markets that need to apply a drug or product to the skin. IMO
This should truly be an epic run for the books. I’m very happy with my shares.
Vilacto Bio Canada Patent LACTOACTIVE® Granted
Press Release | 03/15/2019
NEW YORK, March 15, 2019 (GLOBE NEWSWIRE) -- Denmark-based Vilacto Bio Inc. (OTC QB:VIBI) is happy to announce that the Canadian Intellectual Property Office (CIPO) has informed the Company that its patent application for LACTOACTIVE® will be issued in near future.
The Company has already filed and received patents covering LACTOACTIVE® in the US, Europe and Hong Kong. The Canadian patent, when issued, is expected to give the company greater scope to continue developing the LACTOACTIVE® compound and bolster its international IP ownership position.
The patent applications in Canada also cover the Company’s new compound, LACTOACTIVE iTHER®, a LACTOACTIVE® variant that offers potent immune-system enhancement with a potential for treating a wide range of diseases. LACTOACTIVE iTHER® is expected to generate new revenue streams in addition to the company’s LACTOACTIVE®-based therapeutic skincare range.
“Vilacto Bio now is in a stronger position than ever to leverage the potential of LACTOACTIVE,” said Vilacto Bio CEO Gert Anderson.
Thank you. Saved me the call. I appreciate it.
Well that blows! No wonder it can’t move.
SORRY CORRECTION TO MY POST: I meant it’s traded about half the OUTSTANDING SHARES!
Outstanding Shares: 200,440,000
10q:
Common stock; $0.001 par value; 1,125,000,000 shares authorized; 110,440,000 and 90,000,000 shares issued and outstanding as of December 31, 2018 and March 31, 2018, respectively
Got a position at 19.
Looks like it’s traded about half the float already this morning.
Float: 200,440,000
From the 10q:
Common stock; $0.001 par value; 1,125,000,000 shares authorized; 110,440,000 and 90,000,000 shares issued and outstanding as of December 31, 2018 and March 31, 2018, respectively
Before rushing to an assumption I think we should consider that a settlement was made and there was No mention of issuing shares.
Also, Daniel has made it very clear his intentions to buyback shares. So, assuming this is “debt” financing may be a bit presumptuous.
Think about it; Daniel is going to buyback shares he just issued.
This settlement is probably just that. It’s settled for $185000.
Just my opinion
Sweet! Congrats on the low entry!
I got back in today. OTC never fails to entertain. I would hit the ask and the price would drop. Yep, head stomper. Happened three times all 2.4mil purchased in the last 30min.
I’m about 70% feeling this will breakout and launch prior to the slew of PRs for the simple fact that the judgment ruling is in our favor. It sets a clear path for continued success. Daniel has stated he wants to work with those that have infringed on our patent. I feel we are going to see partnerships/ownership positions and large cash payments coming to BRKK.
VERY SOON.
IMO